References
  1. Jorge AJL, Cordeiro JR, Rosa MLG, et al. Vitamin D Deficiency and Cardiovascular Diseases. Int. J. Cardiovasc. Sci.  Aug 2018;31(4)422-432 https://doi.org/10.5935/2359-4802.20180025.
  2. Nibbelink KA, Tishkoff DX, Hershey SD, et al. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007;103:533–537.
  3. Wu-Wong JR, Nakane M, Ma J, et al. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006 May;186(1):20–8.
  4. Merke J, Milde P, Lewicka S, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989 Jun;83(6):1903–15.
  5. Cantorna MT, Mahon BD. D-hormone and the immune system. J Rheumatol Suppl. 2005;76:11-20.
  6. Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the rennin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):387-92.
  7. Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007 Sep;7(9):684-700.
  8. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29;117(4):503-11.
  9. Lee JH, Keefe JHO, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008 Dec 9;52(24):1949-56.
  10. Kheiri B, Abdalla A, Osman M, et al. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018 Jun 22;24:9.
  11. Mithal A, Wahl DA, Burckhardt P, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009 Nov;20(11):1807–20.
  12. Van Ballegooijen AJ, Kestenbaum B, Sachs MC, et al. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2014 Apr 1;63(12):1214-22.
  13. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010 Jan 21;362(3):228–38.
  14. Gullestad L, Ueland T, Vinge LE, et al. Inflammatory cytokines in heart failure: mediators and markers. Cardiology. 2012;122(1):23–35.
  15. Yuan W, Pan W, Kong J, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007 Oct 12;282(41):29821-30.
  16. Connell JM, Mackenzie SM, Freel EM, et al. A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr. Rev. 2008 Apr; 29(2):133-54.
  17. Sunbul M, Bozbay M, Mammadov C, et al. Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk. Int J Cardiovasc Imaging. 2015 Apr;31(4):765-72.
  18. Omidi F, Hosseinsabet A. Is the longitudinal deformation of the left ventricle affected by vitamin D deficiency in nondiabetics? A 2D speckle-tracking echocardiographic study. Echocardiography. 2019 Jan;36(1):67-73.
  19. Davarpasand T. Vitamin D deficiency as a seed in a fertile soil: A proposed hypothesis. Echocardiography. 2019 May;36(5):1019.
  20. Gómez-Alonso C, Naves-Díaz ML, Fernández-Martín JL, et al. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl. 2003 Jun;(85):S44-8.
  21. Terrovitis J, Zotos P, Kaldara E, et al. Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance Eur J Heart Fail. 14(3):326-32
  22. Schillaci G, Pucci G, Pirro M, et al. Large-artery stiffness: A reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis, 2011;218:98-101
  23. Rosa J, Raska I Jr, Wichterle D, et al. Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertens Res, 2011 Mar,34(3);296-300.
  24. Atasever A, Özdemir E, Acar T, et al. The effect of successful parathyroid surgery on left ventricle function in patients with primary hyperparathyroidism evaluated with strain echocardiography. Echocardiography. 2020 May;37(5):670-677.
  25. Kırış A, Erem C, Kırış G, et al. The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism. Echocardiography. 2011 Oct;28(9):955-60.
  26. Smith JC, Page MD, John R, et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab, 2000 Oct;85(10):3515-9.
  27. Rothe HM, Liangos O, Biggar P, et al. Cinecalcet Treatment of primary hyperparathyroidisim. Int J Endocrinol, 2011; 2011:415719.
  28. Pirro M, Manfredelli MR, Helou RS, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012;19(10):924-31.
  29. El Khoudary SR. Age at menopause onset and risk of cardiovascular disease around the world. Maturitas. 2020 Nov;141:33-38.
  30. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011 Jul;96(7):1911–1930.
  31. Lang RM, Badano LP, Mor-avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015 Jan;28(1):1–39.e14.
  32. Shingu Y, Amorim P, Nguyen TD, et al. Myocardial performance (Tei) index is normal in diastolic and systolic heart failure induced by pressure overload in rats, Eur J Echocardiogr, 2010 Dec;11(10):829-33.
  33. Tafreshi RI, Human N, Otukesh H, et al. Evaluation of combined left ventricular function using the myocardial performance index in children with chronic kidney disease. Echocardiography. 2011 Jan;28(1):97-103.
  34. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr. 2008 Feb;21(2):93-111; quiz 189-90.
  35. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force, J Am Coll Cardiol. 2002 Jan 16;39(2):257-65.
  36. Bots ML, Westerink J, Rabelink TJ, et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response, European Heart Journal, Volume 26, Issue 4, February 2005, Pages 363–368.
  37. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006 Mar;81(3):353-73.
  38. Saiki H, Kuwata S, Kurishima C, et al. Aldosterone-cortisol imbalance immediately after Fontan operation with implications for abnormal fluid homeostasis. Am J Cardiol 2014;114:1578–1583.
  39. Schnatz PF, Nudy M, Jiang X, et al. Vitamin D deficiency and cardiovascular disease in postmenopausal women: contributions from human and nonhuman primate studies. Menopause. 2015 May;22(5):554-63.
  40. Islam MZ, Viljakainen HT, Kärkkäinen MU, et al. Prevalence of vitamin D deficiency and secondary hyperparathyroidism during winter in premenopausal Bangladeshi and Somali immigrant and ethnic Finnish women: associations with forearm bone mineral density. Br J Nutr. 2012 Jan;107(2):277-83.
  41. Pandit A, Mookadam F, Boddu S, et al. Vitamin D levels and left ventricular diastolic function. Open Heart. 2014 Feb 15;1(1):e000011.
  42. Pilz S, Henry RM, Snijder MB, et al. Vitamin D deficiency and myocardial structure and function in older men and women: the Hoorn study. J Endocrinol Invest. 2010 Oct;33(9):612-7.
  43. Iqbal A, Jorde R, Lunde P, et al. Left ventricular dysfunction in subjects with mild secondary hyperparathyroidism detected with pulsed wave tissue Doppler echocardiography. Cardiology. 2006;105(1):1-8.
  44. Lim S, Shin H, Kim MJ, et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab. 2012 Jan;97(1):169-78.
  45. Zang L, Fu P, Huang YQ, et al. [Vitamin D deficiency and carotid artery intima-media thickness and coronary calcification in patients with diabetic nephropathy]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 May;43(3):420-4, 450. Chinese.
  46. Ng YM, Lim SK, Kang PS, et al. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients. BMC Nephrol. 2016 Oct 18;17(1):151.
  47. Costa AF, Barufaldi F, Silveira MA, et al. Association of PTH and carotid thickness in patients with chronic kidney failure and secondary hyperparathyroidism. J Bras Nefrol. 2014 Jul-Sep;36(3):315-9. English, Portuguese.
  48. Anderson JL, Vanwoerkom RC, Horne BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent factors? Am Heart J 2011; 162:331–339.